S. A. Forbes

757 citations
7 papers · 491 indexed · h-index 6
Topics
Neuroendocrine Tumor Research Advances (6 papers)Pancreatic and Hepatic Oncology Research (2 papers)Neuroblastoma Research and Treatments (2 papers)

In The Last Decade

S. A. Forbes

7 papers receiving 473 citations

Peers

S. A. Forbes
Comparison fields: 5 of 41
  • Epidemiology 371
  • Oncology 284
  • Neurology 249
  • Nephrology 98
  • Molecular Biology 80
Replace Masako Kanbe with:
Masako Kanbe Japan
Clark Oh United Kingdom
C J Lips Netherlands
Lily Yang United States
Brita Nord Sweden
Claire Coire Canada
Amira Mohamed France
Stiina Välimäki Sweden
Léopoldine Bricaire France
Margareta Telenius‐Berg Sweden
S. A. Forbes relative to Masako Kanbe Japan Masako Kanbe's profile →
Citations per field
00.5×4.4×
Masako Kanbe · 1×
Citations per year

Countries citing papers authored by S. A. Forbes

Since Specialization
Citations

This map shows the geographic impact of S. A. Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. A. Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. A. Forbes more than expected).

Fields of papers citing papers by S. A. Forbes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. A. Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. A. Forbes. The network helps show where S. A. Forbes may publish in the future.

Co-authorship network of co-authors of S. A. Forbes

This figure shows the co-authorship network connecting the top 25 collaborators of S. A. Forbes. A scholar is included among the top collaborators of S. A. Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. A. Forbes. S. A. Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 48
2 19
3 39
4 32
5 295
6 1
7
Definition of the Minimal MEN1 Candidate Area Based on a 5-Mb Integrated Map of Proximal 11q13
57

About S. A. Forbes

S. A. Forbes is a scholar working on Nephrology, Epidemiology and Oncology, having authored 7 papers that have together received 491 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (6 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Neurology (249 citations), Nephrology (98 citations) and Epidemiology (371 citations). S. A. Forbes has collaborated with scholars based in United Kingdom, Germany and France. Frequent co-authors include Rajesh V. Thakker, A. A. J. Pannett, Brian Harding, J. H. Duncan Bassett, Caitlin Edwards, G. M. Besser, Paul T. Christie, Julian R. Sampson, Malcolm H. Wheeler and John Wass. Their work appears in journals such as The American Journal of Human Genetics, Journal of Bone and Mineral Research and Clinical Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026